The effect of surgical wounding on tumour development

被引:113
作者
Hofer, SOP
Molema, G
Hermens, RAEC
Wanebo, HJ
Reichner, JS
Hoekstra, HJ
机构
[1] Univ Groningen Hosp, Dept Surg, NL-9700 RB Groningen, Netherlands
[2] Univ Groningen Hosp, Dept Tumour Biol, Sect Tumour Immunol, NL-9700 RB Groningen, Netherlands
[3] Brown Univ, Roger Williams Med Ctr, Dept Surg, Providence, RI 02912 USA
[4] Brown Univ, Rhode Isl Hosp, Dept Surg, Div Surg Res, Providence, RI 02903 USA
来源
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY | 1999年 / 25卷 / 03期
关键词
wound healing; tumour development; growth factors; angiogenesis;
D O I
10.1053/ejso.1998.0634
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
For more than a century, a role for wound healing in the outgrowth of tumours has been implied based on observations in both experimental and clinical studies. Wound healing can be divided into stages of inflammatory, proliferative, repair and remodelling processes. Through proper regulation of activation of epithelial, endothelial and inflammatory cells, platelets and fibroblasts, and the production of growth factors, wounds heal and the various cell types resume their normal function, In tumour growth, similar processes of cell activation and growth factor production are observed. These processes are, however, differently regulated leading to ongoing cellular activation. In recent years, growth factors such as EGF, TGF-alpha and TGF-beta, bFGF, IGF I and II, and PDGF have been identified to play a role in the different stages of wound healing. In addition, some of these factors have now been identified as also being involved in the outgrowth of tumours, In this review, cell types involved in wound healing and tumour growth, as well as the growth factors and cytokines they produce and the role of the extracellular matrix, extensively present in both conditions, are being discussed. A better understanding of the time interval during which the sequelae of events in wound healing occur in relation to the time interval of tumour recurrence may be the basis for defining new therapeutic strategies that can interfere with tumour outgrowth without affecting wound healing processes, These new therapeutic approaches may be of importance especially after surgery or other invasive (diagnostic) procedures in cancer patients.
引用
收藏
页码:231 / 243
页数:13
相关论文
共 153 条
[1]   The prognostic significance of basic fibroblast growth factor in cutaneous malignant melanoma [J].
AlAlousi, S ;
Barnhill, R ;
Blessing, K ;
Barksdale, S .
JOURNAL OF CUTANEOUS PATHOLOGY, 1996, 23 (06) :506-510
[2]  
ALBERTSON S, 1993, SURGERY, V114, P368
[3]  
ALLEVA DG, 1994, J IMMUNOL, V153, P1674
[4]   MALIGNANT EPITHELIAL-CELLS IN PRIMARY HUMAN LUNG CARCINOMAS COEXPRESS INVIVO PLATELET-DERIVED GROWTH-FACTOR (PDGF) AND PDGF RECEPTOR MESSENGER-RNAS AND THEIR PROTEIN PRODUCTS [J].
ANTONIADES, HN ;
GALANOPOULOS, T ;
NEVILLEGOLDEN, J ;
OHARA, CJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (09) :3942-3946
[5]   Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model [J].
Arap, W ;
Pasqualini, R ;
Ruoslahti, E .
SCIENCE, 1998, 279 (5349) :377-380
[6]   ANTI-TRANSFORMING GROWTH-FACTOR (TGF)-BETA ANTIBODIES INHIBIT BREAST-CANCER CELL TUMORIGENICITY AND INCREASE MOUSE SPLEEN NATURAL-KILLER-CELL ACTIVITY - IMPLICATIONS FOR A POSSIBLE ROLE OF TUMOR-CELL HOST TGF-BETA INTERACTIONS IN HUMAN BREAST-CANCER PROGRESSION [J].
ARTEAGA, CL ;
HURD, SD ;
WINNIER, AR ;
JOHNSON, MD ;
FENDLY, BM ;
FORBES, JT .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) :2569-2576
[7]  
BAKER DG, 1989, SURGERY, V106, P525
[8]   Cancer research - Designing therapies that target tumor blood vessels [J].
Barinaga, M .
SCIENCE, 1997, 275 (5299) :482-484
[9]  
BATTEGAY EJ, 1995, J MOL MED, V73, P333
[10]   REGIONAL EXPRESSION OF C-FOS AND HEAT-SHOCK PROTEIN-70 MESSENGER-RNA FOLLOWING HYPOXIA ISCHEMIA IN IMMATURE RAT-BRAIN [J].
BLUMENFELD, KS ;
WELSH, FA ;
HARRIS, VA ;
PESENSON, MA .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1992, 12 (06) :987-995